Search Results - "Houwink, Elisa J. F"

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines by Lunenburg, Carin A T C, van der Wouden, Cathelijne H, Nijenhuis, Marga, Crommentuijn-van Rhenen, Mandy H, de Boer-Veger, Nienke J, Buunk, Anne Marie, Houwink, Elisa J F, Mulder, Hans, Rongen, Gerard A, van Schaik, Ron H N, van der Weide, Jan, Wilffert, Bob, Deneer, Vera H M, Swen, Jesse J, Guchelaar, Henk-Jan

“…Despite advances in the field of pharmacogenetics (PGx), clinical acceptance has remained limited. The Dutch Pharmacogenetics Working Group (DPWG) aims to…”
Get full text

Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners by van Vliet, Margo E, Kerkhoffs, Jean-Louis H, Harteveld, Cornelis L, Houwink, Elisa J F

“…The prevalence of hemoglobinopathies in The Netherlands is increasing due to migration. Hemoglobinopathies are severe hereditary diseases. An informed…”
Get full text

Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels by Houwink, Elisa J F, Muijtjens, Arno M M, van Teeffelen, Sarah R, Henneman, Lidewij, Rethans, Jan Joost, Jacobi, Florijn, van der Jagt, Liesbeth, Stirbu, Irina, van Luijk, Scheltus J, Stumpel, Connie T R M, Meijers-Heijboer, Hanne E, van der Vleuten, Cees, Cornel, Martina C, Dinant, Geert Jan

“…General practitioners (GPs) are increasingly called upon to identify patients at risk for hereditary cancers, and their genetic competencies need to be…”
Get full text

Comment on Future trends in clinical genetic and genomic services by Borle et al by Houwink, Elisa J F

Get full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics by Beunk, Lianne, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Guchelaar, Henk Jan, Houwink, Elisa J F, Risselada, Arne, Rongen, Gerard A P J M, van Schaik, Ron H N, Swen, Jesse J, Touw, Daan, van Westrhenen, Roos, Deneer, Vera H M, van der Weide, Jan

“…The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines…”
Get full text

Comment on Australian public perspectives on genomic data governance by Lynch et al. in the EJHG by Houwink, Elisa J F, Klee, Eric W

Get full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs by Brouwer, Jurriaan M J L, Nijenhuis, Marga, Soree, Bianca, Guchelaar, Henk-Jan, Swen, Jesse J, van Schaik, Ron H N, Weide, Jan van der, Rongen, Gerard A P J M, Buunk, Anne-Marie, de Boer-Veger, Nienke J, Houwink, Elisa J F, van Westrhenen, Roos, Wilffert, Bob, Deneer, Vera H M, Mulder, Hans

“…The Dutch Pharmacogenetics Working Group (DPWG) guideline presented here, presents the gene-drug interaction between the genes CYP2C19 and CYP2D6 and…”
Get full text

Hemoglobinopathy prevention in primary care: a reflection of underdetection and difficulties with accessibility of medical care, a quantitative study by van Vliet, Margo E, Kerkhoffs, Jean-Louis H, Harteveld, Cornelis L, Houwink, Elisa J F

“…As in most Northern European countries, the prevalence of hemoglobinopathies in The Netherlands is increasing due to migration. Although hemoglobinopathies are…”
Get full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) by Matic, Maja, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Houwink, Elisa J F, Mulder, Hans, Rongen, Gerard A P J M, Weide, Jan van der, Wilffert, Bob, Swen, Jesse J, Guchelaar, Henk-Jan, Deneer, Vera H M, van Schaik, Ron H N

“…The current Dutch Pharmacogenetics Working Group (DPWG) guideline, describes the gene-drug interaction between CYP2D6 and the opioids codeine, tramadol and…”
Get full text

Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate by van der Pol, Karel H, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne Marie, Guchelaar, Henk-Jan, Risselada, Arne, van Schaik, Ron H N, Swen, Jesse J, Touw, Daan, van der Weide, Jan, van Westrhenen, Roos, Deneer, Vera H M, Houwink, Elisa J F, Rongen, Gerard A

“…The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize…”
Get full text

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan by Hulshof, Emma C, Deenen, Maarten J, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Houwink, Elisa J F, Risselada, Arne, Rongen, Gerard A P J M, van Schaik, Ron H N, Touw, Daan J, van der Weide, Jan, van Westrhenen, Roos, Deneer, Vera H M, Guchelaar, Henk-Jan, Swen, Jesse J

“…The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize…”
Get full text

Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate by Nijenhuis, Marga, Soree, Bianca, Jama, Wafa O M, de Boer-Veger, Nienke J, Buunk, Anne Marie, Guchelaar, Henk-Jan, Houwink, Elisa J F, Rongen, Gerard A, van Schaik, Ron H N, Swen, Jesse J, Touw, Daan, van der Weide, Jan, van Westrhenen, Roos, Deneer, Vera H M, Risselada, Arne

“…Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in…”
Get full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants by Beunk, Lianne, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Guchelaar, Henk-Jan, Houwink, Elisa J F, Risselada, Arne, Rongen, Gerard A P J M, van Schaik, Ron H N, Swen, Jesse J, Touw, Daan, Deneer, Vera H M, van Westrhenen, Roos

“…The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines…”
Get full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs by Manson, Lisanne E N, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Houwink, Elisa J F, Risselada, Arne, Rongen, Gerard A P J M, van Schaik, Ron H N, Swen, Jesse J, Touw, Daan J, van Westrhenen, Roos, Deneer, Vera H M, Guchelaar, Henk-Jan

“…By developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy, the Dutch Pharmacogenetics Working Group (DPWG) aims to advance the…”
Get full text

Modernizing family health history: achievable strategies to reduce implementation gaps by Wildin, Robert S., Messersmith, Donna J., Houwink, Elisa J. F.

“…Family health history (FHH) is a valuable yet underused healthcare tool for assessing health risks for both prevalent disorders like diabetes, cancer, and…”
Get full text

FHH Quick App Review: How Can a Quality Review Process Assist Primary Care Providers in Choosing a Family Health History App for Patient Care? by Wood, Grant M, van Boom, Sander, Recourt, Kasper, Houwink, Elisa J. F

“…Family health history (FHH) is a data type serving risk assessment, diagnosis, research, and preventive health. Despite technological leaps in genomic variant…”
Get full text

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan by Hulshof, Emma C, Deenen, Maarten J, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J, Buunk, Anne-Marie, Houwink, Elisa J F, Risselada, Arne, Rongen, Gerard A P J M, van Schaik, Ron H N, Touw, Daan J, van der Weide, Jan, van Westrhenen, Roos, Deneer, Vera H M, Guchelaar, Henk-Jan, Swen, Jesse J

Get full text

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) by Matic, Maja, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J., Buunk, Anne-Marie, Houwink, Elisa J. F., Mulder, Hans, Rongen, Gerard A. P. J. M., Weide, Jan van der, Wilffert, Bob, Swen, Jesse J., Guchelaar, Henk-Jan, Deneer, Vera H. M., van Schaik, Ron H. N.

Get full text

SERIES: eHealth in primary care. Part 2: Exploring the ethical implications of its application in primary care practice by Boers, Sarah N., Jongsma, Karin R., Lucivero, Federica, Aardoom, Jiska, Büchner, Frederike L., de Vries, Martine, Honkoop, Persijn, Houwink, Elisa J. F., Kasteleyn, Marise J., Meijer, Eline, Pinnock, Hilary, Teichert, Martina, van der Boog, Paul, van Luenen, Sanne, van der Kleij, Rianne M. J. J., Chavannes, Niels H.

“…eHealth promises to increase self-management and personalised medicine and improve cost-effectiveness in primary care. Paired with these promises are ethical…”
Get full text

Personal Genomes in Practice: Exploring Citizen and Healthcare Professionals' Perspectives on Personalized Genomic Medicine and Personal Health Data Spaces Using a Mixed-Methods Design by Tommel, Judith, Kenis, Daan, Lambrechts, Nathalie, Brohet, Richard M, Swysen, Jordy, Mollen, Lotte, Hoefmans, Marie-José F, Pusparum, Murih, Evers, Andrea W M, Ertaylan, Gökhan, Roos, Marco, Hens, Kristien, Houwink, Elisa J F

“…Ongoing health challenges, such as the increased global burden of chronic disease, are increasingly answered by calls for personalized approaches to…”
Get full text